Janux Therapeutics Inc (JANX)
54.98
+0.77
(+1.42%)
USD |
NASDAQ |
Nov 08, 12:56
Janux Therapeutics Revenue (TTM): 15.13M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 15.13M |
March 31, 2024 | 7.287M |
December 31, 2023 | 8.083M |
September 30, 2023 | 8.467M |
June 30, 2023 | 7.763M |
March 31, 2023 | 9.071M |
Date | Value |
---|---|
December 31, 2022 | 8.612M |
September 30, 2022 | 7.383M |
June 30, 2022 | 6.729M |
March 31, 2022 | 4.846M |
December 31, 2021 | 3.637M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.637M
Minimum
Dec 2021
15.13M
Maximum
Jun 2024
7.910M
Average
7.763M
Median
Jun 2023
Revenue (TTM) Benchmarks
Dynavax Technologies Corp | 249.70M |
Krystal Biotech Inc | 241.52M |
Arcus Biosciences Inc | 263.00M |
NovaBay Pharmaceuticals Inc | 12.02M |
Palatin Technologies Inc | -- |